Viewing StudyNCT00486668



Ignite Creation Date: 2024-05-05 @ 5:34 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00486668
Status: UNKNOWN
Last Update Posted: 2016-06-06
First Post: 2007-06-13

Brief Title: A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
Sponsor: NSABP Foundation Inc
Organization: NSABP Foundation Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-07
Start Date Type: None
Primary Completion Date: 2012-06
Primary Completion Date Type: ACTUAL
Completion Date: 2017-03
Completion Date Type: ESTIMATED
First Submit Date: 2007-06-13
First Submit QC Date: June 13 2007
Study First Post Date: 2007-06-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-06-03
Last Update Post Date: 2016-06-06
Last Update Post Date Type: ESTIMATED